Rossari Biotech

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: INE02A801020
  • NSEID: ROSSARI
  • BSEID: 543213
INR
490.40
9.95 (2.07%)
BSENSE

May 06

BSE+NSE Vol: 1.73 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
684.86
581.68
586.11
543.72
579.56
512.73
498.35
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
684.86
581.68
586.11
543.72
579.56
512.73
498.35
Raw Material Cost
444.47
417.60
407.21
334.40
369.77
321.48
324.36
Purchase of Finished goods
24.10
10.97
29.39
28.96
33.88
45.99
42.34
(Increase) / Decrease In Stocks
27.16
-27.77
-35.75
7.99
-2.01
-17.42
-26.00
Employee Cost
39.23
40.26
37.80
37.47
35.49
35.69
32.56
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
0.01
0.00
0.01
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
72.66
71.75
75.53
67.04
72.93
62.23
59.15
Total Expenditure (Excl Depreciation)
607.61
512.81
514.19
475.86
510.07
447.97
432.41
Operating Profit (PBDIT) excl Other Income
77.25
68.87
71.92
67.86
69.49
64.76
65.94
Other Income
19.07
0.51
1.60
1.20
1.79
0.55
0.72
Operating Profit (PBDIT)
96.32
69.38
73.52
69.06
71.28
65.31
66.66
Interest
9.06
7.67
6.09
5.73
5.50
4.94
3.68
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
87.26
61.71
67.43
63.33
65.78
60.37
62.98
Depreciation
23.53
19.61
18.23
17.75
18.22
18.32
15.16
Profit Before Tax
64.24
42.50
49.67
46.10
47.71
42.38
48.11
Tax
18.28
9.73
12.80
12.50
13.26
10.68
12.78
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
45.46
32.37
36.41
33.08
34.29
31.37
35.04
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
45.46
32.37
36.41
33.08
34.29
31.37
35.04
Share in Profit of Associates
0.51
0.40
0.47
0.52
0.15
0.33
0.29
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
45.97
32.77
36.88
33.60
34.44
31.70
35.33
Equity Capital
11.08
11.08
11.07
11.07
11.07
11.07
11.06
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
8.3
5.92
6.66
6.07
6.22
5.73
6.39
Diluted Earnings per share
8.29
5.91
6.65
6.06
6.21
5.72
6.38
Operating Profit Margin (Excl OI)
11.28%
11.84%
12.27%
12.48%
11.99%
12.63%
13.23%
Gross Profit Margin
12.74%
10.61%
11.5%
11.65%
11.35%
11.77%
12.64%
PAT Margin
6.71%
5.63%
6.29%
6.18%
5.94%
6.18%
7.09%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is 17.74% vs -0.76% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 40.28% vs -11.14% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 12.17% vs -4.24% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is 18.12% vs 25.94% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

Compare Quarterly Results Of Rossari Biotech With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
684.86
183.71
501.15
272.79%
Other Operating Income
0.00
0.00
0.00
Total Operating income
684.86
183.71
501.15
272.79%
Raw Material Cost
444.47
116.51
327.96
281.49%
Purchase of Finished goods
24.10
6.03
18.07
299.67%
(Increase) / Decrease In Stocks
27.16
-3.57
30.73
860.78%
Employee Cost
39.23
10.27
28.96
281.99%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
72.66
19.64
53.02
269.96%
Total Expenditure (Excl Depreciation)
607.61
148.88
458.73
308.12%
Operating Profit (PBDIT) excl Other Income
77.25
34.83
42.42
121.79%
Other Income
19.07
6.75
12.32
182.52%
Operating Profit (PBDIT)
96.32
41.58
54.74
131.65%
Interest
9.06
0.23
8.83
3,839.13%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
87.26
41.35
45.91
111.03%
Depreciation
23.53
3.33
20.20
606.61%
Profit Before Tax
64.24
38.02
26.22
68.96%
Tax
18.28
7.91
10.37
131.10%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
45.46
30.12
15.34
50.93%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
45.46
30.12
15.34
50.93%
Share in Profit of Associates
0.51
0.00
0.51
Minority Interest
0.00
3.77
-3.77
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
45.97
26.35
19.62
74.46%
Equity Capital
11.08
115.95
-104.87
-90.44%
Face Value
2.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
8.30
0.45
7.85
1,744.44%
Diluted Earnings per share
8.29
0.26
8.03
3,088.46%
Operating Profit Margin (Excl OI)
11.28%
18.96%
0.00
-7.68%
Gross Profit Margin
12.74%
22.51%
0.00
-9.77%
PAT Margin
6.71%
16.40%
0.00
-9.69%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 684.86 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 17.74% vs -0.76% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 18.17% vs 22.60% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 45.97 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 40.28% vs -11.14% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 33.48% vs 0.91% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 77.25 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 12.17% vs -4.24% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 11.17% vs 9.28% in Mar 2025

Quarterly - Interest
Interest 9.06 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 18.12% vs 25.94% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 64.73% vs 118.25% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.28%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025